ArticleCancer research and treatment2023

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer.

Jang Ho Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.